The Effects of Iontophoresis in Women With Gynoid Hidrolipodystrophy.

Status Completed

Clinical Trial Summary

Introduction: Gynoid hydrolipodystrophy (HLDG) or cellulitis is a subcutaneous tissue disorder, with several strategies for its treatment, such as caffeine and iontophoresis. Objective: To evaluate the effects of caffeine-associated iontophoresis for the treatment of HLDG. Methods: In a longitudinal study, participants will be evaluated for: photographic documentation, ultrasound imaging, thermography and quality of life questionnaire. If included, they will be separated into 3 randomized groups (n = 30). G1: use of base gel (n = 10); G2: use of iontophoresis and gel with caffeine (n = 10) and G3: use of iontophoresis alone (n = 10). The groups will be treated with 10 sessions, 2 times per week. After that they will be reevaluated. Statistical analysis: The software used will be the SPSS StatisticalPackage (IBM SPSS Statistics, Chicago, IL, USA). The data distribution will be analyzed by the Shapiro-Wilk test. In case of normal distribution, the data will be described as mean ± standard deviation; otherwise, as median [interquartile range 25-75%]. For comparison of the data, we will use ANOVA and for comparison of means the Tukey test and case not normal distribution, krulskal-Wallis test and the Dunns test. The level of statistical significance adopted will be P <0.05. Expected contributions: It is expected that investigators can contribute to the treatment of patients with HLDG and analyze the effects of iontophoresis with caffeine, both in clinical and scientific practice, providing a method that is valid and reliable for this purpose; multidisciplinary training of highly qualified human resources and the strengthening and consolidation of a research team.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03556917
Study type	Interventional
Source	Universidade Norte do Paraná
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	June 14, 2018
Completion date	April 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06038903` - The Turkish Version Of The Brief-Caffeine Expectancy Questionnaire
Completed	`NCT02900261` - Study on Sodium and Caffeine in Children and Adolescents
Completed	`NCT03850275` - The Effects of e+Shots Energy Beverage on Mental Energy	N/A
Completed	`NCT01924481` - Effects of a Cocoa Shot on the Human Brain	N/A
Completed	`NCT01330680` - Genetic Determinants of Cardiovascular Response to Coffee Drinking	N/A
Completed	`NCT00184912` - The Effect of Caffeine on Ischemic Preconditioning	N/A
Completed	`NCT03859882` - Protocol PERCAF 2018	N/A
Completed	`NCT02832401` - The Impact of Caffeine on Cognition in Schizophrenia	N/A
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Recruiting	`NCT05503732` - Effects of Energy Drinks on Sleep and Cardiovascular Health	N/A
Not yet recruiting	`NCT05521386` - The Effects of Caffeine on Heart Rate and Heart Rate Variability	N/A
Completed	`NCT06039358` - Effects of Caffeine Ingestion on the Biomechanics of Healthy Young Subjects	N/A
Active, not recruiting	`NCT04547868` - Can Coffee/Caffeine Improve Post-Operative Gastrointestinal Recovery	N/A
Completed	`NCT05559372` - Energy Drink Effects on Performance, Mood, and Cardiovascular Outcomes	N/A
Completed	`NCT01783561` - Early Versus Routine Caffeine Administration in Extremely Preterm Neonates	Phase 4
Completed	`NCT04852315` - Acute Caffeine Ingestion on Futsal Performance	N/A
Completed	`NCT05975489` - Genetics in the Effect of Caffeine on Fat Oxidation	N/A
Recruiting	`NCT03298347` - Caffeine for Preterm Infants With Apnea of Prematurity(AOP)	N/A
Completed	`NCT01435486` - Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants	N/A
Completed	`NCT04869176` - Effect of Caffeine on Heart Rate Variability in Newborns	N/A